Status:
ACTIVE_NOT_RECRUITING
Equity in Prevention and Progression of Hypertension by Addressing Barriers to Nutrition and Physical activitY
Lead Sponsor:
University of Alabama at Birmingham
Conditions:
Prehypertension
Hypertension
Eligibility:
All Genders
19+ years
Phase:
NA
Brief Summary
The goal of this study is to test an intervention to prevent high blood pressure among rural, Black adults living in Alabama. Black adults in this region have one of the highest rates of high blood pr...
Eligibility Criteria
Inclusion
- Self-identify as Black/African American
- Mean systolic blood pressure 120-139mmHg OR diastolic blood pressure 80-89mmHg
Exclusion
- Mean systolic blood pressure greater than or equal to140 mm Hg, or mean diastolic blood pressure greater than or equal to 90 mm Hg
- Currently taking antihypertensive medication
- Self-reported history of hypertension outside of pregnancy
- Known pregnancy
- Self-reported history of cardiovascular disease
- Age ≥65 years or self-reported history of chronic kidney disease, or diabetes, if systolic blood pressure ≥ 130 mm Hg or diastolic blood pressure ≥ 80
- Planning to move out of the county within the next 18 months
- Not having a cellular phone or landline
- Inability to speak English
Key Trial Info
Start Date :
August 13 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2026
Estimated Enrollment :
528 Patients enrolled
Trial Details
Trial ID
NCT05367544
Start Date
August 13 2022
End Date
September 1 2026
Last Update
April 6 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Alabama At Birmingham
Birmingham, Alabama, United States, 35205